Clinical TrialID 4789
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NCT02777242
Hypogonadism
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 4789
- Evidence Id
- 4789
- Core Evidence Id
- 4789
- Source Clinical Trial Id
- 4762
- Herb2 Clinical Trial Id
- HBCT004762
- Nct Id
- NCT02777242
- Title
- Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
- Status
- Completed
- Phase
- Phase 2
- Study Result
- Yes
- Study Condition
- Hypogonadism
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- COMBINATION_PRODUCT: Testosterone enanthate auto-injector
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Male
- Age
- Adult, Older_Adult
- Enrollment
- 66
- Outcome Measure
- Number of Patients With Adverse Events Receiving Testosterone Enanthate Via QST Auto-injector., Intended users were patients experiencing an adverse event that was considered to be a TEAE if the adverse event started on or after randomization, or existed prior to randomization and worsened in severity or relatedness to QST (QuickShot® Testosterone auto-injector) after randomization., 3 weeks
- Sponsor Collaborator
- Antares Pharma Inc.
- Funded By
- INDUSTRY
- Location
- Birmingham, Alabama, 35235, United States|New York, New York, 10016, United States|Columbus, Ohio, 43213, United States
- Other Id
- QST-16-006
- Start Date
- 2016-06
- Primary Completion Date
- 2016-08
- Completion Date
- 2016-08
- First Posted
- 2016-05-19
- Results First Posted
- 2018-02-26
- Last Update Posted
- 2018-03-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02777242
- Title Cn
- Title En
- Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
- Bilingual Status
- semi_complete